SHINGRIX is an FDA-approved vaccine for the prevention of shingles (herpes zoster) in adults 50 years and older. SHINGRIX is not used to prevent chickenpox. Important Safety Information • You should not receive SHINGRIX if you are allergic to any of its ingredients or had an allergic reactio...
US authorization of first COVID vaccine marks new phase in safety monitoring Could mixing COVID vaccines boost immune response? How COVID unlocked the power of RNA vaccines Search for better COVID vaccines confounded by existing rollouts Oxford COVID-vaccine paper highlights lingering unknowns...
More than 9 million doses of COVID-19 vaccines have been administered across China, and the safety and efficacy of the vaccines have been proved, a top health official said. With production increasing, the number of vaccine doses will be extended to cover the whole Chinese...
COVID-19 Vaccine SafetyThe following sections are included:Key MessageIntroductionPre-Clinical and Clinical Trials for the COVID-19 VaccinesPhase 4: Post-Marketing SurveillanceCOVID-19 Vaccine Safety for PopulationsCOVID-19 Vaccine Types and AdjuvantsConclusionReferences...
Health Alert on mRNA COVID-19 Vaccine Safety The COVID-19 pandemic brought many challenges that the health and medical field have never encountered. Although the initial response was led by a sense of urgency and crisis management, the State Surgeon General believes it is critical that as publi...
Health authorities are still doing some safety checks on the vaccine but the government says it wants to start administering it as soon as possible. The approval of the Russian and Chinese vaccines in Hungary has been controversial, with the Chamber of Doctors recently ...
Twenty-three serious outcomes were considered, selected based on data from the phase 3 clinical trial results for the mRNA vaccines (eg, Bell palsy, appendicitis), COVID-19 disease concerns (eg, acute myocardial infarction, acute respiratory distress syndrome), and other historical vaccine safety ...
Study reveals COVID-19 vaccine safety in patients with atrial fibrillation/flutter Development of the coronavirus disease 2019 (COVID-19) vaccine has been key to countering the pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Despite the current endemic status of CO...
et al. Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates. N. Engl. J. Med. 383, 2439–2450 (2020). Article CAS PubMed Google Scholar Baden, L. R. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. 384, 403–416 (2021)....
Can “vaccine passports” guarantee safety in the face of borders reopening? How will our lives be re-shaped by this new form of identification? And what challenges lie ahead? To find out more, we’ve invited Wang Dan, chief economist at Hang Seng Bank in China; Dr. Mary Stephen, ...